| Dr Elias Dagnew, MD | |
|
9635 Ventana Way Ste 201, Johns Creek, GA 30022-8622 | |
| (404) 446-4424 | |
| (404) 446-4420 |
| Full Name | Dr Elias Dagnew |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 27 Years |
| Location | 9635 Ventana Way Ste 201, Johns Creek, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962408930 | NPI | - | NPPES |
| 838984626A | Medicaid | GA | |
| 277245100 | Medicaid | FL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emory Johns Creek Hospital | Johns creek, GA | Hospital |
| Piedmont Mountainside Hospital Inc | Jasper, GA | Hospital |
| Union General Hospital | Blairsville, GA | Hospital |
| Northside Hospital | Atlanta, GA | Hospital |
| Northside Hospital Cherokee | Canton, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Georgia Brain And Spine Center | 0042351025 | 3 |
News Archive
TetraLogic Pharmaceuticals announced today that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety and tolerability of TL32711 in adults with solid tumors or lymphoma refractory to standard therapies. The study will also assess the pharmacokinetics, pharmacodynamics and anti-tumor activity of TL32711.
Researchers have found that antibodies against the human papillomavirus (HPV) may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx, which is a portion of the throat that contains the tonsils.
Researchers at Erasmus Medical Center have demonstrated systemic spread of avian influenza virus in cats infected by respiratory, digestive, and cat-to-cat contact.
In addition to the Chamber's approach, news outlets detailed the National Taxpayers' Union plans once the repeal vote is over to focus on certain tax provisions in the new law that the Obama administration may be willing to address. Also, experts on Minnesota Public Radio discuss the political positioning and implementation action at the state level.
› Verified 3 days ago
| Entity Name | Georgia Brain & Spine Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871723684 PECOS PAC ID: 0042351025 Enrollment ID: O20100113000342 |
News Archive
TetraLogic Pharmaceuticals announced today that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety and tolerability of TL32711 in adults with solid tumors or lymphoma refractory to standard therapies. The study will also assess the pharmacokinetics, pharmacodynamics and anti-tumor activity of TL32711.
Researchers have found that antibodies against the human papillomavirus (HPV) may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx, which is a portion of the throat that contains the tonsils.
Researchers at Erasmus Medical Center have demonstrated systemic spread of avian influenza virus in cats infected by respiratory, digestive, and cat-to-cat contact.
In addition to the Chamber's approach, news outlets detailed the National Taxpayers' Union plans once the repeal vote is over to focus on certain tax provisions in the new law that the Obama administration may be willing to address. Also, experts on Minnesota Public Radio discuss the political positioning and implementation action at the state level.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elias Dagnew, MD 11877 Douglas Rd, Suite 102-272, Alpharetta, GA 30005-4325 Ph: (404) 446-4424 | Dr Elias Dagnew, MD 9635 Ventana Way Ste 201, Johns Creek, GA 30022-8622 Ph: (404) 446-4424 |
News Archive
TetraLogic Pharmaceuticals announced today that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety and tolerability of TL32711 in adults with solid tumors or lymphoma refractory to standard therapies. The study will also assess the pharmacokinetics, pharmacodynamics and anti-tumor activity of TL32711.
Researchers have found that antibodies against the human papillomavirus (HPV) may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx, which is a portion of the throat that contains the tonsils.
Researchers at Erasmus Medical Center have demonstrated systemic spread of avian influenza virus in cats infected by respiratory, digestive, and cat-to-cat contact.
In addition to the Chamber's approach, news outlets detailed the National Taxpayers' Union plans once the repeal vote is over to focus on certain tax provisions in the new law that the Obama administration may be willing to address. Also, experts on Minnesota Public Radio discuss the political positioning and implementation action at the state level.
› Verified 3 days ago
Dr. Michael G. Hartman, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9635 Ventana Way Ste 201, Johns Creek, GA 30022 Phone: 404-446-4424 Fax: 404-446-4420 |